Amgen
Generated by Meeveem AI
"A worldwide biotechnology pioneer serving patients with life-changing biologic medicines"
About Amgen
Amgen discovers, develops, manufactures and delivers medicines for serious diseases, including biologic medicines made using living cells. Its four therapeutic areas are oncology, inflammation, general medicine and rare disease. The company reaches millions of patients and has a presence in approximately 100 countries worldwide.
Founded in 1980 and headquartered in Thousand Oaks, California, Amgen combines human genetics, disease biology and technology to develop treatments. Its portfolio and research pipeline address conditions including cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen reported approximately 31,500 staff worldwide at 31 December 2025.
UK operations
Amgen’s UK commercial and research and development operations are based in Cambridge and Uxbridge. Its UK organisation describes itself as a European research and development hub, with approximately 650 staff. Cambridge Science Park has hosted Amgen for more than 25 years; the Uxbridge Development Centre opened in 2007.
31500
Team Members
1980
Founded
Biotechnology
Sector
On-Site
Work Environment